Alvarez-González I, Madrigal-Bujaidar E, Dorado V, Espinosa-Aguirre J J
Laboratorio de Citogenética, Facultad de Estudios Superiores Cuautitlán, UNAM, Mexico City, Mexico.
Mutat Res. 2001 Sep 1;480-481:171-8. doi: 10.1016/s0027-5107(01)00197-x.
Naringin (Nar) is a flavonone found in high amount in grapefruit. In in vitro studies to determine its antimutagenicity results have been both positive and negative. On the other hand, an increase in the bioavailability of some medicaments have been observed when these are ingested together with grapefruit. It has been suggested that the effect may be related to the inhibition of the human enzyme Cytochrome P450 (CYP) 3A4 by Nar, an enzyme with a high aminoacid sequence homology with the Cyp3a in mouse. The present study was designed for three main purposes: (1) to determine whether Nar has a genotoxic effect in mouse in vivo. This was evaluated by measuring the rate of micronucleated polychromatic erythrocytes (MNPE); (2) to determine its antigenotoxic and its anticytotoxic potential on the damage produced by ifosfamide (Ifos). The first study was done by scoring the rate of MNPE, and the second one by establishing the index polychromatic erythrocytes/normochromatic erythrocytes (PE/NE); and (3) to explore whether its antigenotoxic mechanism of action is related to an inhibitory effect of Nar on the expression of the Cyp3a enzyme, an effect which could avoid the biotransformation of Ifos. A single oral administration was used for all groups in the experiment: three groups were given different doses of Nar (50, 250, and 500 mg/kg), other groups received the same doses of Nar plus an administration of Ifos (60 mg/kg), another group treated with distilled water and another with Ifos (60 mg/kg) were used as negative and positive controls, respectively. The micronuclei and the cell scoring were made in blood samples taken from the tail of the animals at 0, 24, 48, 72, and 96 h. The results showed that Nar was neither genotoxic nor cytotoxic with the doses tested, but Ifos produced an increase in the rate of MNPE at 24 and 48 h. The highest value was 24+/-1.57 MNPE per thousand cells at 48 h. The index PE/NE was significantly reduced by Ifos at 24 and 48 h. Concerning the antigenotoxic capacity of Nar, a significant decrease was observed in the MNPE produced by Ifos at the three tested doses. This effect was dose-dependent, showing the highest reduction in MNPE frequency (54.2%) at 48 h with 500 mg/kg of Nar. However, no protection on the cytotoxicity produced by Ifos was observed. Immunoblot analysis was used to assess the Cyp3a expression in liver and intestinal microsomes from mouse exposed orally to Nar. An induction in the Cyp3a protein was observed in both intestinal and hepatic microsomes from treated mice. This induction correlated with an increase in erythromycin N-demethylase activity. These data suggest that other mechanism(s) are involved in the antigenotoxic action of naringin.
柚皮苷(Nar)是一种在葡萄柚中大量存在的黄酮酮。在体外研究中,关于其抗诱变作用的结果既有阳性的也有阴性的。另一方面,当一些药物与葡萄柚一起摄入时,已观察到它们的生物利用度有所提高。有人提出,这种作用可能与Nar对人类细胞色素P450(CYP)3A4酶的抑制有关,该酶与小鼠的Cyp3a具有高度的氨基酸序列同源性。本研究旨在实现三个主要目的:(1)确定Nar在小鼠体内是否具有遗传毒性作用。这通过测量微核多色红细胞(MNPE)的发生率来评估;(2)确定其对异环磷酰胺(Ifos)产生的损伤的抗遗传毒性和抗细胞毒性潜力。第一项研究通过对MNPE的发生率进行评分来完成,第二项研究通过建立多色红细胞/正色红细胞指数(PE/NE)来完成;(3)探讨其抗遗传毒性作用机制是否与Nar对Cyp3a酶表达的抑制作用有关,这种作用可以避免Ifos的生物转化。实验中所有组均采用单次口服给药:三组给予不同剂量的Nar(50、250和500mg/kg),其他组接受相同剂量的Nar加一次Ifos给药(60mg/kg),另一组用蒸馏水治疗,另一组用Ifos(60mg/kg)分别作为阴性和阳性对照。在0、24、48、72和96小时从动物尾部采集血液样本进行微核和细胞评分。结果表明,在所测试的剂量下,Nar既没有遗传毒性也没有细胞毒性,但Ifos在24和48小时时使MNPE的发生率增加。最高值在48小时时为每千个细胞24±1.57个MNPE。Ifos在24和48小时时使PE/NE指数显著降低。关于Nar的抗遗传毒性能力,在三个测试剂量下,Ifos产生的MNPE均显著降低。这种作用呈剂量依赖性,在48小时时,500mg/kg的Nar使MNPE频率降低最多(54.2%)。然而,未观察到对Ifos产生的细胞毒性的保护作用。免疫印迹分析用于评估口服Nar的小鼠肝脏和肠道微粒体中Cyp3a的表达。在处理过的小鼠的肠道和肝脏微粒体中均观察到Cyp3a蛋白的诱导。这种诱导与红霉素N-脱甲基酶活性的增加相关。这些数据表明,柚皮苷的抗遗传毒性作用涉及其他机制。